INVA
Innoviva IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.70B
P/E Ratio
7.01
EPS
$3.28
Beta
0.38
52W High
$25.14
52W Low
$16.52
50-Day MA
$23.00
200-Day MA
$20.60
Dividend Yield
—
Profit Margin
65.90%
Forward P/E
11.95
PEG Ratio
0.34
About Innoviva Inc
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
Fundamentals
| Revenue (TTM) | $411.33M |
| Gross Profit (TTM) | $308.23M |
| EBITDA | $194.99M |
| Operating Margin | 34.70% |
| Return on Equity | 29.10% |
| Return on Assets | 7.18% |
| Revenue/Share (TTM) | $6.10 |
| Book Value | $15.71 |
| Price-to-Book | 1.46 |
| Price-to-Sales (TTM) | 4.14 |
| EV/Revenue | 3.437 |
| EV/EBITDA | 3.82 |
| Quarterly Earnings Growth (YoY) | 590.00% |
| Quarterly Revenue Growth (YoY) | 24.80% |
| Shares Outstanding | $74.05M |
| Float | $69.26M |
| % Insiders | 0.67% |
| % Institutions | 108.01% |
Historical Volatility
HV 10-Day
17.85%
HV 20-Day
22.79%
HV 30-Day
22.01%
HV 60-Day
25.18%
HV Rank
34.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($33.20 target)
4
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026